45 articles
Maria Milla, MD, Section Chief, Nicklaus Children's Pediatric Care Centers discusses the importance of flu vaccinations for children and their parents e...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s MF59® Adjuvanted, Trivalent Influenza Vaccine that...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s cell-based quadrivalent influenza vaccine (QIVc), whi...
Maria Milla, M.D., Section Chief, Nicklaus Children's Pediatric Care Centers discusses pediatric immunizations and the recommendation to not delay wheth...
John Lewis, Ph.D., CEO of Aegis Life, Inc., a spinout of Entos Pharmaceuticals, discusses the company's goal of developing a novel DNA vaccine using its...
Len Friedland, Vice President and Director, Scientific Affairs and Public Health, Vaccines, at GSK discusses how the ordering rate of adult vaccines amo...
Dave Anderson, Chief Scientific Officer at VBI Vaccines discusses the company's work to develop a pan-coronavirus vaccine to address mutations. He tal...
Phil Dormitzer, VP and CSO, Viral Vaccines at Pfizer Vaccines Research and Development discusses the significance of new data presented at the 2019 IDWe...
The range of options for children aged six months & older & the first & only adjuvanted seasonal influenza vaccine developed for people aged 65 & older.
Pneumococcal Pneumonia is just one vaccine-preventable disease that boomers should help protect themselves against. Learn more on Health Professional Radio.